Related Experiment Video
Updated: Mar 29, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
Chimeric Antigen Receptor T-Cell Therapy-Associated Infections in Hematologic Malignancies: A Real-World
Xiangyang Ding1, Kexin Ai1, Suwan Wu1
1Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Abstract:
Chimeric antigen receptor T-cell therapy-related adverse events have become a focus of clinical attention. However, a comprehensive study of infection-related adverse events remains scarce, especially for high-risk, life-threatening infections. To provide real-world evidence from a pharmacovigilance perspective for monitoring infection-related adverse events. This study investigated the characteristics of infection-related adverse events using the Food and Drug Administration Adverse Event Reporting System database. The disproportionality analysis was used to calculate the reporting odds ratios of infections. Time to onset (TTO) and outcomes were analyzed to describe the temporal distribution and severity of infections. The least absolute shrinkage and selection operator (LASSO) regression was used to screen death-associated infections. The co-occurrence analysis was utilized to investigate the mechanism of infection occurrence. A total of 2142 reports of infection-related adverse events were obtained, accounting for 17.6% of total reports. At the high-level term (HLT) level, 31 positive safety signals were identified, including 12 bacterial infections, 12 viral infections, 4 fungal infections, 2 organ-specific infections, and 1 other infection. The median TTO of infections was 6 d (interquartile range: 2 to 24). The HLT-level positive signals with death proportions exceeding 50% predominantly pertained to sepsis-related infections, fungal infections, and Gram-negative bacterial infections. The LASSO analysis further demonstrated that those infections were associated with fatal outcomes. The co-occurrence analysis indicated that infections were associated with immune dysregulation. The prevalence, early onset, and broad spectrum of infection-related adverse events necessitate clinical attention. High-risk infections, including sepsis-related infections, fungal infections, and Gram-negative bacterial infections, especially warrant heightened vigilance.
More Related Videos
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Related Concept Videos
Tumor Immunotherapy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Cell-mediated Immune Responses